WO2023120180A1 - Oil-in-water type emulsified cosmetic - Google Patents
Oil-in-water type emulsified cosmetic Download PDFInfo
- Publication number
- WO2023120180A1 WO2023120180A1 PCT/JP2022/045021 JP2022045021W WO2023120180A1 WO 2023120180 A1 WO2023120180 A1 WO 2023120180A1 JP 2022045021 W JP2022045021 W JP 2022045021W WO 2023120180 A1 WO2023120180 A1 WO 2023120180A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- formula
- carbon atoms
- oil
- cosmetic
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
Definitions
- the present invention relates to an oil-in-water emulsified cosmetic.
- oil-in-water emulsified cosmetics it is common to stably mix an aqueous component and an oily component by the emulsifying action of a surfactant or the like. Since the oil is surrounded by the emulsifier and the outer phase is a continuous layer of the aqueous phase, it is said to have an excellent feeling of freshness when used.
- an oil-in-water emulsified cosmetic using core-corona type particles as a dispersant has been proposed (for example, Patent Document 1). With regard to such cosmetics, there is room for further improvement in the user's feeling of use, especially in terms of freshness.
- cyclic carboxamide derivatives are known to have anti-wrinkle and anti-pigmentation effects, and have been proposed to be added to cosmetics (for example, Patent Document 2).
- R 1 is a hydroxyalkyl group having 1 to 3 carbon atoms
- component (A) is 1-(2-hydroxyethyl)-2-imidazolidinone.
- the polymerization solvent is a water-alcohol mixed solvent, and said alcohol is selected from the group consisting of ethanol, dipropylene glycol, 1,3-butylene glycol, and isoprene glycol; and (iv) said water-alcohol.
- R 11 is a hydrogen atom or an alkyl group having 1 to 3 carbon atoms
- R 12 is a hydrogen atom or a methyl group
- nb is a number from 8 to 200
- R 13 is a hydrogen atom or an alkyl group having 1 to 3 carbon atoms
- R 14 is an alkyl group having 1 to 12 carbon atoms
- R 15 is a hydrogen atom or an alkyl group having 1 to 3 carbon atoms
- R 16 and R 17 are each independently a hydrogen atom or an alkyl group having 1 to 18 carbon atoms
- the cosmetic according to [5], wherein the radical polymerization conditions further include the following conditions (v):
- the radical polymerization is carried out in the presence of a crosslinkable monomer, and the charge amount of the crosslinkable monomer is 1.5 mass % or less with respect to the charge amount of the hydrophobic monomer.
- an oil-in-water emulsified cosmetic with an excellent feeling of use.
- freshness can be imparted during application.
- the present invention comprises (A) a cyclic carboxamide derivative having a specific structure or a salt thereof, (B) core-corona type particles, (C) oil, and (D) water, and (B) core-corona type
- the particles are particles obtained by radical polymerization of a polyethylene oxide macromonomer and a hydrophobic monomer selected from the group consisting of acrylic acid/methacrylic acid derivative monomers and acrylamide/methacrylamide derivative monomers. It relates to cosmetics (hereinafter sometimes referred to as cosmetics).
- the cosmetic according to the present invention includes (A) a cyclic carboxamide derivative represented by formula (a) or a salt thereof (hereinafter sometimes referred to as component (A). Other components) is the same.).
- component (A) a cyclic carboxamide derivative represented by formula (a) or a salt thereof (hereinafter sometimes referred to as component (A).
- component (A) is the same.
- R 1 is a hydrocarbon group having 1 to 6 carbon atoms which may be substituted with a hydroxyl group, or a hydrogen atom
- X is —CH 2 — or —N(R 2 )—
- R 2 is a hydrocarbon group having 1 to 6 carbon atoms which may be substituted with a hydroxyl group, or a hydrogen atom
- na is an integer of 1-3.
- the above hydrocarbon group is not particularly limited, and may be, for example, an alkyl group, a cycloalkyl group, an alkenyl group, an alkynyl group, a cycloalkylalkyl group, a haloalkyl group, an alkoxyalkyl group, or an alkoxycarbonylalkyl group, preferably is an alkyl group.
- R 1 is a hydroxyalkyl group having 1 to 3 carbon atoms
- X is —CH 2 — or —NH—
- na is 1.
- Specific examples of the cyclic carboxamide derivative represented by formula (a) include the following.
- Component (A) is most preferably 1-(2-hydroxyethyl)-2-imidazolidinone.
- the (A) component may be a salt of the cyclic carboxamide derivative represented by formula (a).
- the type of salt is not particularly limited as long as it is a pharmacologically acceptable salt, and may be an inorganic salt or an organic salt.
- inorganic salts include hydrochlorides, sulfates, phosphates, hydrobromides, sodium salts, potassium salts, magnesium salts, calcium salts, magnesium salts, ammonium salts and the like.
- organic salts include acetates, lactates, maleates, fumarates, tartrates, methanesulfonates, p-toluenesulfonates, triethanolamine salts, amino acid salts and the like.
- component (A) component can be blended one or two or more.
- the blending amount of component (A) is preferably 0.05 to 5% by mass, more preferably 0.3 to 3.5% by mass, and still more preferably 0.5% by mass, relative to the total amount of the cosmetic. ⁇ 2% by mass.
- the cosmetic according to the present invention comprises (B) core-corona particles.
- the core-corona type particles suitably used in the present invention are particles having a core portion made of a relatively highly hydrophobic polymer and a corona portion stabilized with a polyethylene oxide chain, which is a nonionic polymer. be. Due to the polyethylene oxide chain in the corona portion, it has excellent dispersion stability in water and acid and salt resistance.
- the particle size of the core-corona type particles is preferably substantially constant, and the average particle size is preferably 50 to 400 nm, more preferably 100 to 300 nm.
- the average particle size can be optically measured by a dynamic light scattering method or the like, and for example, Datasizer manufactured by Malvern can be used.
- the dispersity of the core-corona type particles is preferably less than 0.2, more preferably less than 0.05.
- Component (B) is particles obtained by radical polymerization of a polyethylene oxide macromonomer and a hydrophobic monomer selected from the group consisting of acrylic acid/methacrylic acid derivative monomers and acrylamide/methacrylamide derivative monomers.
- radical polymerization is carried out under the following conditions (i) to (iv).
- Condition (i) is that "the molar ratio represented by the charged molar amount of the polyethylene oxide macromonomer and the charged molar amount of the hydrophobic monomer is 1:10 to 1:250".
- the molar ratio of charged molar amount of polyethylene oxide macromonomer to charged molar amount of hydrophobic monomer is preferably 1:10 to 1:200, more preferably 1:25 to 1:100. This range is preferable from the viewpoint of formation of core-corona type particles and dispersion stabilization.
- Condition (ii) is "the polyethylene oxide macromonomer is represented by formula (b1), the acrylic acid/methacrylic acid derivative monomer is represented by formula (b2), and the acrylamide/methacrylamide derivative monomer is represented by formula (b3). Is Rukoto.
- the polyethylene oxide macromonomer is preferably represented by formula (b1). (In the formula, R 11 is a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, R 12 is a hydrogen atom or a methyl group, and nb is a number from 8 to 200)
- polyethylene oxide macromonomer for example, a commercially available product from Aldrich or a commercial product such as BLEMMER (registered trademark) from NOF CORPORATION can be used.
- BLEMMER registered trademark
- Acrylic acid/methacrylic acid derivative monomers are preferably represented by formula (b2).
- R 13 is a hydrogen atom or an alkyl group having 1 to 3 carbon atoms
- R 14 is an alkyl group having 1 to 12 carbon atoms
- Acrylic acid/methacrylic acid derivative monomers include, for example, methyl acrylate, ethyl acrylate, propyl acrylate, butyl acrylate, pentyl acrylate, hexyl acrylate, heptyl acrylate, octyl acrylate, decyl acrylate, acrylic dodecyl acid, methyl methacrylate, ethyl methacrylate, propyl methacrylate, butyl methacrylate, pentyl methacrylate, hexyl methacrylate, heptyl methacrylate, octyl methacrylate, decyl methacrylate, dodecyl methacrylate and the like.
- methyl methacrylate (methyl methacrylate), butyl methacrylate (butyl methacrylate), and octyl methacrylate are particularly preferred.
- Commercially available products from, for example, Aldrich Co. or Tokyo Kasei Co., Ltd. can also be used as these.
- the acrylamide/methacrylamide derivative monomer is preferably represented by formula (b3).
- R 15 is a hydrogen atom or an alkyl group having 1 to 3 carbon atoms
- R 16 and R 17 are each independently a hydrogen atom or an alkyl group having 1 to 18 carbon atoms
- Acrylamide/methacrylamide derivative monomers include, for example, t-butylacrylamide, N,N-dimethylacrylamide, N-[3-(dimethylamino)propyl]acrylamide, t-butylmethacrylamide, octylacrylamide, octylmethacrylamide, octadecyl acrylamide and the like.
- t-butylacrylamide, N,N-dimethylacrylamide, and N-[3-(dimethylamino)propyl]acrylamide are particularly preferred. These are available as commercial products or industrial raw materials.
- the hydrophobic monomer used in the present invention is one or more selected from the group consisting of acrylic acid/methacrylic acid derivative monomers and acrylamide/methacrylamide derivative monomers. , methyl methacrylate and butyl methacrylate, or four of methyl methacrylate, t-butylacrylamide, N,N-dimethylacrylamide and N-[3-(dimethylamino)propyl]acrylamide.
- methoxypolyethylene glycol monomethacrylate as macromonomer.
- Condition (iii) is that "the polymerization solvent is a water-alcohol mixed solvent, and the alcohol is selected from the group consisting of ethanol, dipropylene glycol, 1,3-butylene glycol, and isoprene glycol".
- the water:alcohol ratio is 80-20:20-80.
- the dissolving ability of the hydrophobic monomer does not become too low, which is preferable from the viewpoint of the generation of microparticles. It is preferable because more microparticles are obtained.
- Radical polymerization can be carried out in the presence or absence of crosslinkable monomers.
- the radical polymerization conditions further include the following conditions (v).
- the condition (v) is that "radical polymerization is carried out in the presence of a crosslinkable monomer, and the amount of the crosslinkable monomer charged is 1.5% by mass or less with respect to the amount of the hydrophobic monomer charged.”
- the cross-linking monomer is hydrophobic.
- ethylene glycol dimethacrylate hereinafter sometimes abbreviated as EGDMA
- Blemmer registered trademark
- PDE-50 sold by NOF, and the like
- the crosslinkable monomer is represented by formula (b4). (In the formula, R 18 and R 19 are each independently an alkyl group having 1 to 3 carbon atoms, mb is a number from 1 to 3)
- the (B) component is preferably an (acrylamide/DMAPA acrylate/methoxy PEG methacrylate) copolymer or an (acrylates/methoxy PEG-90 methacrylate) crosspolymer.
- the component (B) can be blended either alone or in combination of two or more.
- the blending amount of component (B) is preferably 0.05 to 3% by mass, more preferably 0.1 to 1.5% by mass, based on the total amount of the cosmetic.
- composition (C) Oil The cosmetic according to the present invention comprises (C) oil.
- Component (C) includes, for example, ester oils, silicone oils, hydrocarbon oils, higher fatty acids, higher alcohols, liquid oils, solid oils, semi-solid oils and the like, preferably hydrocarbon oils, silicone oils and ester oils. selected from the group consisting of oils;
- ester oils include octyl octanoate, nonyl nonanoate, cetyl octanoate, isopropyl myristate, octyldodecyl myristate, isopropyl palmitate, ethylhexyl palmitate, butyl stearate, hexyl laurate, myristyl myristate, and oleic acid.
- silicone oils include linear polysiloxanes (e.g., dimethicone, diphenylsiloxyphenyl trimethicone, diphenylpolysiloxane, etc.), cyclic polysiloxanes (e.g., octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexasiloxane, siloxane, etc.), silicone resins that form a three-dimensional network structure, silicone rubber, various modified polysiloxanes (amino-modified polysiloxane, polyether-modified polysiloxane, alkyl-modified polysiloxane, fluorine-modified polysiloxane, etc.), acrylic silicones etc., preferably chain polysiloxane.
- linear polysiloxanes e.g., dimethicone, diphenylsiloxyphenyl trimethicone, diphen
- hydrocarbon oils examples include isododecane, isohexadecane, isoparaffin, mineral oil (liquid paraffin), ozokerite, squalane, pristane, paraffin, ceresin, squalene, petrolatum, microcrystalline wax, and hydrogenated polydecene.
- higher fatty acids examples include lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, oleic acid, undecylenic acid, toric acid, isostearic acid, linoleic acid, linoleic acid, eicosapentaenoic acid (EPA), docosahexaenoic acid ( DHA) and the like.
- Higher alcohols include, for example, straight-chain alcohols (eg, lauryl alcohol, cetyl alcohol, stearyl alcohol, behenyl alcohol, myristyl alcohol, oleyl alcohol, cetostearyl alcohol, etc.), branched-chain alcohols (eg, lanolin alcohol, cholesterol, phytosterol, hexyldodecanol, isostearyl alcohol, octyldodecanol, etc.).
- straight-chain alcohols eg, lauryl alcohol, cetyl alcohol, stearyl alcohol, behenyl alcohol, myristyl alcohol, oleyl alcohol, cetostearyl alcohol, etc.
- branched-chain alcohols eg, lanolin alcohol, cholesterol, phytosterol, hexyldodecanol, isostearyl alcohol, octyldodecanol, etc.
- Liquid oils include, for example, avocado oil, camellia oil, macadamia nut oil, corn oil, olive oil, rapeseed oil, sesame oil, persic oil, wheat germ oil, sasanqua oil, castor oil, linseed oil, safflower oil, cottonseed oil, and eno oil. , soybean oil, peanut oil, tea seed oil, kaya oil, rice bran oil, sinagiri oil, Japanese pear oil, jojoba oil, germ oil, triglycerin and the like.
- solid oils include cacao butter, coconut oil, hydrogenated coconut oil, palm oil, palm kernel oil, hydrogenated palm oil, Japanese wax kernel oil, hydrogenated oil, Japanese wax, and hydrogenated castor oil.
- Semi-solid oils include, for example, shea butter, partially hydrogenated coconut oil, partially hydrogenated jojoba oil, and the like.
- component (C) component can be blended one or two or more.
- the blending amount of component (C) is preferably 0.5 to 30% by mass, more preferably 1 to 15% by mass, based on the total amount of the cosmetic.
- the cosmetic according to the present invention contains (D) water.
- water water used in cosmetics, quasi-drugs, etc. can be used, and for example, purified water, ion-exchanged water, tap water, etc. can be used.
- the amount of water to be blended is preferably 30-95% by mass, more preferably 60-90% by mass, based on the total amount of the cosmetic composition according to the present invention.
- the cosmetic according to the present invention can further contain a surfactant.
- Surfactants include amphoteric surfactants, cationic surfactants, nonionic surfactants, and anionic surfactants, preferably nonionic surfactants.
- the blending amount of the surfactant is preferably 1% by mass or less, more preferably 0.5% by mass or less, and even more preferably 0% by mass, relative to the total amount of the cosmetic. 0.2% by mass or less, particularly preferably 0.1% by mass or less. Not containing a surfactant (0% by mass) is also a preferred embodiment of the present invention.
- the cosmetics according to the present invention can contain optional ingredients that are usually used in cosmetics and pharmaceuticals.
- Optional ingredients include other ingredients commonly used in cosmetics, such as lower alcohols, humectants, thickeners, sequestering agents, neutralizers, pH adjusters, antioxidants, preservatives, and drugs. As long as it is possible and the effects of the present invention are exhibited, one or more of them can be blended.
- lower alcohols examples include ethanol, 1-propanol, 2-propanol, isobutyl alcohol, t-butyl alcohol and the like.
- moisturizing agents examples include polyethylene glycol, propylene glycol, glycerin, 1,3-butylene glycol (BG), erythritol, xylitol, sorbitol, maltitol, chondroitin sulfate, hyaluronic acid, mucoitin sulfate, caronin acid, atelocollagen, cholesteryl- 12-hydroxystearate, sodium lactate, bile salts, dl-pyrrolidone carboxylate, short-chain soluble collagen, rose rose extract, yarrow extract, melilot extract and the like.
- BG 1,3-butylene glycol
- Thickeners include, for example, gum arabic, carrageenan, karaya gum, tragacanth gum, carob gum, quince seed (quince), casein, dextrin, gelatin, sodium pectate, sodium araginate, methylcellulose, ethylcellulose, CMC, hydroxyethylcellulose, hydroxypropyl Cellulose, PVA, PVM, PVP, sodium polyacrylate, carboxyvinyl polymer (carbomer), (dimethylacrylamide/acryloyldimethyltaurate Na) crosspolymer, (acryloyldimethyltaurate ammonium/VP) copolymer, (acryloyldimethyltaurate ammonium methacrylate) Henneth-25) Crosspolymer, (Na acrylate/Na acryloyldimethyltaurate) copolymer, locust bean gum, guar gum, tamarind gum, dialkyldimethylammonium cellulose sulfate
- sequestering agents include 1-hydroxyethane-1,1-diphosphonic acid, tetrasodium 1-hydroxyethane-1,1-diphosphonic acid, disodium edetate (EDTA-2Na), and trisodium edetate.
- EDTA-2Na disodium edetate
- trisodium edetate tetrasodium edetate, sodium citrate, sodium polyphosphate, sodium metaphosphate, gluconic acid, phosphoric acid, citric acid, succinic acid, edetic acid, trisodium ethylenediaminehydroxyethyl triacetate, and the like.
- neutralizing agents examples include 2-amino-2-methyl-1-propanol, 2-amino-2-methyl-1,3-propanediol, potassium hydroxide, sodium hydroxide, triethanolamine, sodium carbonate, and the like. are mentioned.
- pH adjusters include buffers such as lactic acid-sodium lactate, citric acid-sodium citrate, and succinic acid-sodium succinate.
- antioxidants include dibutylhydroxytoluene, butylhydroxyanisole, sodium pyrosulfite, and gallic acid esters.
- antiseptics include paraoxybenzoic acid esters such as methylparaben, ethylparaben, and butylparaben, benzoic acid, salicylic acid, sorbic acid, parachlorometacresol, hexachlorophene, benzalkonium chloride, chlorhexidine chloride, and trichlorocarbanilide. , a photosensitive element, phenoxyethanol, and the like.
- drugs include ascorbic acid (vitamin C), tranexamic acid, kojic acid, ellagic acid, arbutin, alkoxysalicylic acid, glycyrrhizic acid, tocopherol, retinol, and salts or derivatives thereof (e.g., sodium L-ascorbate, L -ascorbic acid ester magnesium salt, L-ascorbic acid glucoside, 2-O-ethyl-L-ascorbic acid, 3-O-ethyl-L-ascorbic acid, 4-methoxysalicylic acid sodium salt, 4-methoxysalicylic acid potassium salt, glycyrrhizin dipotassium acid, stearyl glycyrrhizinate, tocopherol acetate, retinol acetate, retinol palmitate, etc.), nicotinic acid or its derivatives (e.g.
- nicotinamide caffeine, tannins, verapamil and its derivatives, licorice extract, glabridin, fire Hot water extract of thorn fruit, various crude drugs, hydrolyzed silk, hydrolyzed conchiolin, tea extract, tormentilla root extract, Angelica keiskei leaf/stem extract, aloe vera leaf extract, cherry leaf extract, angelica root extract, shiikuwasha pericarp extract, iris root extract, thorny rhinoceros / hijirimen / honey kelp / blue laver / wakame seaweed extract, cattail extract, hikiokoshi leaf / stem extract, camellia seed extract, honey kelp / wakame extract, honeysuckle root extract, Dutch mustard leaf / stem extract, cassia bark extract, rose Marie leaf oil, lavender oil, glutamic acid, trimethylglycine, chlorphenesin, menthoxypropanediol and the like.
- UV absorbers can be added as appropriate.
- the method for producing the cosmetic according to the present invention is not particularly limited, and it can be produced according to a conventional method.
- Cosmetics according to the present invention include, for example, skin care cosmetics (e.g. lotions, milky lotions, creams, serums, packs, masks, etc.), makeup cosmetics (e.g., foundations, makeup bases, etc.), skin cleansers (e.g. , face wash, makeup remover, etc.), sunscreen cosmetics, ointments, and the like.
- skin care cosmetics e.g. lotions, milky lotions, creams, serums, packs, masks, etc.
- makeup cosmetics e.g., foundations, makeup bases, etc.
- skin cleansers e.g. , face wash, makeup remover, etc.
- sunscreen cosmetics ointments, and the like.
- Example 1 to 8 and Comparative Examples 1 to 3 Cosmetics of Examples 1 to 8 and Comparative Examples 1 to 3 were prepared with the formulations shown in Table 1. Numerical values in the table indicate % by mass. The viscosities of the obtained cosmetics are shown in Table 1. Viscosity was measured with a Brookfield viscometer (30°C).
- Formulation Examples 1 to 7 of the cosmetic of the present invention are shown in Tables 2 to 8 below. Numerical values in the table indicate % by mass.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
Description
本発明は、水中油型乳化化粧料に関する。 The present invention relates to an oil-in-water emulsified cosmetic.
水中油型乳化化粧料において、界面活性剤等の乳化作用により、水性成分と油性成分を安定に混合することが一般的である。油分が乳化剤で囲まれ、外相は水相の連続層となるため、みずみずしい感触を与える使用感に優れているといわれている。
界面活性剤を用いず、粉末を界面に吸着させることによって乳化される技術として、ピッカリングエマルションという乳化法がある。その中で、コア-コロナ型粒子を分散剤として用いた水中油型乳化化粧料が提案されている(例えば特許文献1)。このような化粧料について、使用者はより優れた使用感、特にみずみずしさについて、さらなる使用感の改善の余地があった。
In oil-in-water emulsified cosmetics, it is common to stably mix an aqueous component and an oily component by the emulsifying action of a surfactant or the like. Since the oil is surrounded by the emulsifier and the outer phase is a continuous layer of the aqueous phase, it is said to have an excellent feeling of freshness when used.
There is an emulsification method called Pickering emulsion as a technique of emulsifying by adsorbing powder to the interface without using a surfactant. Among them, an oil-in-water emulsified cosmetic using core-corona type particles as a dispersant has been proposed (for example, Patent Document 1). With regard to such cosmetics, there is room for further improvement in the user's feeling of use, especially in terms of freshness.
一方、環状カルボキサミド誘導体は、抗しわ効果や色素沈着抑制効果があることが知られており、化粧料等に配合することが提案されている(例えば特許文献2)。 On the other hand, cyclic carboxamide derivatives are known to have anti-wrinkle and anti-pigmentation effects, and have been proposed to be added to cosmetics (for example, Patent Document 2).
本発明者らの検討によると、環状カルボキサミド誘導体を化粧料に用いる場合に、べたつきを生じやすく、みずみずしさを感じにくい傾向にあることがわかってきた。本発明者らは、驚くべきことに、コア-コロナ型粒子と、特定の環状カルボキサミド誘導体との組み合わせを含む水中油型化粧料を用いることで、優れた使用感を達成できることを見いだした。本発明はこれらの知見に基づくものである。 According to the studies of the present inventors, it has been found that when cyclic carboxamide derivatives are used in cosmetics, they tend to be sticky and less likely to feel fresh. The present inventors have surprisingly found that using an oil-in-water cosmetic containing a combination of core-corona type particles and a specific cyclic carboxamide derivative can achieve excellent feeling during use. The present invention is based on these findings.
本発明によれば、以下の発明が提供される。
[1](A)式(a)で表される環状カルボキサミド誘導体またはその塩
R1は、水酸基で置換されていてもよい炭素数1~6の炭化水素基、または水素原子であり、
Xは、-CH2-または-N(R2)-であり、ここで、R2は、水酸基で置換されていてもよい炭素数1~6の炭化水素基、または水素原子であり、かつ
naは、1~3の整数である)、
(B)コア-コロナ型粒子、
(C)油分、および
(D)水
を含んでなり、
(B)コア-コロナ型粒子が、ポリエチレンオキサイドマクロモノマーと、アクリル酸/メタクリル酸誘導体モノマーおよびアクリルアミド/メタクリルアミド誘導体モノマーからなる群から選択される疎水性モノマーとをラジカル重合して得られる粒子である、水中油型乳化化粧料。
[2](A)成分の式(a)において、
R1が、炭素数1~3のヒドロキシアルキル基であり、
Xが、-CH2-または-NH-であり、かつ
naが、1である、[1]に記載の化粧料。
[3](A)成分が、1-(2-ヒドロキシエチル)-2-イミダゾリジノンである、[1]または[2]に記載の化粧料。
[4](A)成分の配合量が、化粧料の総量に対して、0.05~5質量%である、[1]~[3]のいずれかに記載の化粧料。
[5]前記ラジカル重合が下記(i)~(iv)の条件下で行われる、[1]~[4]のいずれかに記載の化粧料:
(i)前記ポリエチレンオキサイドマクロモノマーの仕込みモル量:前記疎水性モノマーの仕込みモル量で表されるモル比が1:10~1:250であること、
(ii)前記ポリエチレンオキサイドマクロモノマーが式(b1)で表され、前記アクリル酸/メタクリル酸誘導体モノマーが式(b2)で表され、前記アクリルアミド/メタクリルアミド誘導体モノマーが式(b3)で表されること、
(iii)重合溶媒が水-アルコール混合溶媒であり、前記アルコールがエタノール、ジプロピレングリコール、1,3-ブチレングリコール、およびイソプレングリコールからなる群から選択されること、および
(iv)前記水-アルコール混合溶媒の溶媒組成が、20℃で、質量比で、水:アルコール=90~10:10~90であること。
R11は、水素原子または炭素数1~3のアルキル基であり、
R12は、水素原子またはメチル基であり、かつ
nbは、8~200の数である)
R13は、水素原子または炭素数1~3のアルキル基であり、かつ
R14は、炭素数1~12のアルキル基である)
R15は、水素原子または炭素数1~3のアルキル基であり、かつ
R16およびR17は、それぞれ独立に、水素原子または炭素数1~18のアルキル基である)
[6]前記ラジカル重合の条件が、さらに下記(v)の条件を含んでなる、[5]に記載の化粧料:
(v)前記ラジカル重合が、架橋性モノマーの存在下に行われ、前記架橋性モノマーの仕込み量が、前記疎水性モノマーの仕込み量に対して、1.5質量%以下であること。
[7]前記架橋性モノマーが式(b4)で表される、[6]に記載の化粧料。
R18およびR19は、それぞれ独立に、炭素数1~3のアルキル基であり、
mbは、1~3の数である)
[8](B)コア-コロナ型粒子の平均粒子径が50~400nmである、[1]~[7]のいずれかに記載の化粧料。
[9](B)コア-コロナ型粒子が、(アクリルアミド/アクリル酸DMAPA/メタクリル酸メトキシPEG)コポリマーまたは(アクリレーツ/メタクリル酸メトキシPEG-90)クロスポリマーである、[1]~[8]のいずれかに記載の化粧料。
[10](B)コア-コロナ型粒子の配合量が、化粧料の総量に対して、0.05~3質量%である、[1]~[9]のいずれかに記載の化粧料。
According to the present invention, the following inventions are provided.
[1] (A) Cyclic carboxamide derivative represented by formula (a) or a salt thereof
R 1 is a hydrocarbon group having 1 to 6 carbon atoms which may be substituted with a hydroxyl group, or a hydrogen atom,
X is —CH 2 — or —N(R 2 )—, wherein R 2 is a hydrocarbon group having 1 to 6 carbon atoms which may be substituted with a hydroxyl group, or a hydrogen atom, and na is an integer of 1 to 3),
(B) core-corona particles;
(C) oil, and (D) water,
(B) The core-corona type particles are particles obtained by radically polymerizing a polyethylene oxide macromonomer and a hydrophobic monomer selected from the group consisting of acrylic acid/methacrylic acid derivative monomers and acrylamide/methacrylamide derivative monomers. There is an oil-in-water emulsified cosmetic.
[2] In the formula (a) of the component (A),
R 1 is a hydroxyalkyl group having 1 to 3 carbon atoms,
The cosmetic according to [1], wherein X is —CH 2 — or —NH— and na is 1.
[3] The cosmetic of [1] or [2], wherein component (A) is 1-(2-hydroxyethyl)-2-imidazolidinone.
[4] The cosmetic according to any one of [1] to [3], wherein the amount of component (A) is 0.05 to 5% by mass relative to the total amount of the cosmetic.
[5] The cosmetic according to any one of [1] to [4], wherein the radical polymerization is performed under the following conditions (i) to (iv):
(i) the molar ratio of the charged molar amount of the polyethylene oxide macromonomer to the charged molar amount of the hydrophobic monomer is 1:10 to 1:250;
(ii) the polyethylene oxide macromonomer is represented by formula (b1), the acrylic acid/methacrylic acid derivative monomer is represented by formula (b2), and the acrylamide/methacrylamide derivative monomer is represented by formula (b3). matter,
(iii) the polymerization solvent is a water-alcohol mixed solvent, and said alcohol is selected from the group consisting of ethanol, dipropylene glycol, 1,3-butylene glycol, and isoprene glycol; and (iv) said water-alcohol. The solvent composition of the mixed solvent is water:alcohol=90-10:10-90 at 20.degree.
R 11 is a hydrogen atom or an alkyl group having 1 to 3 carbon atoms,
R 12 is a hydrogen atom or a methyl group, and nb is a number from 8 to 200)
R 13 is a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, and R 14 is an alkyl group having 1 to 12 carbon atoms)
R 15 is a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, and R 16 and R 17 are each independently a hydrogen atom or an alkyl group having 1 to 18 carbon atoms)
[6] The cosmetic according to [5], wherein the radical polymerization conditions further include the following conditions (v):
(v) The radical polymerization is carried out in the presence of a crosslinkable monomer, and the charge amount of the crosslinkable monomer is 1.5 mass % or less with respect to the charge amount of the hydrophobic monomer.
[7] The cosmetic according to [6], wherein the crosslinkable monomer is represented by formula (b4).
R 18 and R 19 are each independently an alkyl group having 1 to 3 carbon atoms,
mb is a number from 1 to 3)
[8] (B) The cosmetic according to any one of [1] to [7], wherein the core-corona type particles have an average particle size of 50 to 400 nm.
[9] (B) The core-corona particles of [1] to [8], wherein the (acrylamide/DMAPA acrylate/methoxy PEG methacrylate) copolymer or (acrylates/methoxy PEG-90 methacrylate) crosspolymer Cosmetics according to any one of the above.
[10] The cosmetic according to any one of [1] to [9], wherein the content of (B) the core-corona type particles is 0.05 to 3% by mass relative to the total amount of the cosmetic.
本発明によれば、使用感に優れた水中油型乳化化粧料を提供することができる。特に、塗布中にみずみずしさを付与することができる。 According to the present invention, it is possible to provide an oil-in-water emulsified cosmetic with an excellent feeling of use. In particular, freshness can be imparted during application.
本発明は、(A)特定の構造を有する環状カルボキサミド誘導体またはその塩、(B)コア-コロナ型粒子、(C)油分、および(D)水を含んでなり、(B)コア-コロナ型粒子が、ポリエチレンオキサイドマクロモノマーと、アクリル酸/メタクリル酸誘導体モノマーおよびアクリルアミド/メタクリルアミド誘導体モノマーからなる群から選択される疎水性モノマーとをラジカル重合して得られる粒子である、水中油型乳化化粧料(以下、化粧料と称することがある。)に関するものである。 The present invention comprises (A) a cyclic carboxamide derivative having a specific structure or a salt thereof, (B) core-corona type particles, (C) oil, and (D) water, and (B) core-corona type The particles are particles obtained by radical polymerization of a polyethylene oxide macromonomer and a hydrophobic monomer selected from the group consisting of acrylic acid/methacrylic acid derivative monomers and acrylamide/methacrylamide derivative monomers. It relates to cosmetics (hereinafter sometimes referred to as cosmetics).
(A)環状カルボキサミド誘導体またはその塩
本発明による化粧料は、(A)式(a)で表される環状カルボキサミド誘導体またはその塩(以下、(A)成分と称することがある。他の成分についても同様である。)を含んでなる。
R1は、水酸基で置換されていてもよい炭素数1~6の炭化水素基、または水素原子であり、
Xは、-CH2-または-N(R2)-であり、ここで、R2は、水酸基で置換されていてもよい炭素数1~6の炭化水素基、または水素原子であり、かつ
naは、1~3の整数である。
上記の炭化水素基は、特に限定されず、例えば、アルキル基、シクロアルキル基、アルケニル基、アルキニル基、シクロアルキルアルキル基、ハロアルキル基、アルコキシアルキル基、アルコキシカルボニルアルキル基であってよく、好ましくはアルキル基である。
(A) Cyclic carboxamide derivative or salt thereof The cosmetic according to the present invention includes (A) a cyclic carboxamide derivative represented by formula (a) or a salt thereof (hereinafter sometimes referred to as component (A). Other components) is the same.).
R 1 is a hydrocarbon group having 1 to 6 carbon atoms which may be substituted with a hydroxyl group, or a hydrogen atom,
X is —CH 2 — or —N(R 2 )—, wherein R 2 is a hydrocarbon group having 1 to 6 carbon atoms which may be substituted with a hydroxyl group, or a hydrogen atom, and na is an integer of 1-3.
The above hydrocarbon group is not particularly limited, and may be, for example, an alkyl group, a cycloalkyl group, an alkenyl group, an alkynyl group, a cycloalkylalkyl group, a haloalkyl group, an alkoxyalkyl group, or an alkoxycarbonylalkyl group, preferably is an alkyl group.
好ましい形態において、(A)成分の式(a)において、
R1が、炭素数1~3のヒドロキシアルキル基であり、
Xが、-CH2-または-NH-であり、かつ
naが、1である。
式(a)で表される環状カルボキサミド誘導体の具体例としては、例えば、以下が挙げられる。
R 1 is a hydroxyalkyl group having 1 to 3 carbon atoms,
X is —CH 2 — or —NH— and na is 1.
Specific examples of the cyclic carboxamide derivative represented by formula (a) include the following.
(A)成分は、式(a)で表される環状カルボキサミド誘導体の塩であってもよい。塩の種類は、薬理学的に許容される塩であれば特に限定されず、無機塩であっても有機塩であってもよい。無機塩としては、例えば、塩酸塩、硫酸塩、リン酸塩、臭化水素酸塩、ナトリウム塩、カリウム塩、マグネシウム塩、カルシウム塩、マグネシウム塩、アンモニウム塩等が挙げられる。有機塩としては、例えば、酢酸塩、乳酸塩、マレイン酸塩、フマル酸塩、酒石酸塩、メタンスルホン酸塩、p-トルエンスルホン酸塩、トリエタノールアミン塩、アミノ酸塩等が挙げられる。 The (A) component may be a salt of the cyclic carboxamide derivative represented by formula (a). The type of salt is not particularly limited as long as it is a pharmacologically acceptable salt, and may be an inorganic salt or an organic salt. Examples of inorganic salts include hydrochlorides, sulfates, phosphates, hydrobromides, sodium salts, potassium salts, magnesium salts, calcium salts, magnesium salts, ammonium salts and the like. Examples of organic salts include acetates, lactates, maleates, fumarates, tartrates, methanesulfonates, p-toluenesulfonates, triethanolamine salts, amino acid salts and the like.
(A)成分は、1種または2種以上を配合することができる。(A)成分の配合量は、化粧料の総量に対して、好ましくは0.05~5質量%であり、より好ましくは0.3~3.5質量%であり、さらに好ましくは0.5~2質量%である。 (A) component can be blended one or two or more. The blending amount of component (A) is preferably 0.05 to 5% by mass, more preferably 0.3 to 3.5% by mass, and still more preferably 0.5% by mass, relative to the total amount of the cosmetic. ~2% by mass.
(B)コア-コロナ型粒子
本発明による化粧料は、(B)コア-コロナ型粒子を含んでなる。
本発明に好適に用いられるコア-コロナ型粒子は、比較的疎水性の高い高分子からなるコア部を有し、コロナ部分が非イオン性高分子であるポリエチレンオキサイド鎖で安定化された粒子である。コロナ部分のポリエチレンオキサイド鎖により、水中での分散安定性と耐酸性・耐塩性に優れるものである。
(B) Core-Corona Particles The cosmetic according to the present invention comprises (B) core-corona particles.
The core-corona type particles suitably used in the present invention are particles having a core portion made of a relatively highly hydrophobic polymer and a corona portion stabilized with a polyethylene oxide chain, which is a nonionic polymer. be. Due to the polyethylene oxide chain in the corona portion, it has excellent dispersion stability in water and acid and salt resistance.
コア-コロナ型粒子の粒子径はほぼ一定であることが好ましく、平均粒子径は、好ましくは50~400nmであり、より好ましくは100~300nmである。平均粒子径は、動的光散乱法等により光学的に測定することができ、例えば、マルバーン社製データサイザーを用いることができる。
コア-コロナ型粒子の分散度は、好ましくは0.2未満であり、より好ましくは0.05未満である。
The particle size of the core-corona type particles is preferably substantially constant, and the average particle size is preferably 50 to 400 nm, more preferably 100 to 300 nm. The average particle size can be optically measured by a dynamic light scattering method or the like, and for example, Datasizer manufactured by Malvern can be used.
The dispersity of the core-corona type particles is preferably less than 0.2, more preferably less than 0.05.
(B)成分は、ポリエチレンオキサイドマクロモノマーと、アクリル酸/メタクリル酸誘導体モノマーおよびアクリルアミド/メタクリルアミド誘導体モノマーからなる群から選択される疎水性モノマーとをラジカル重合して得られる粒子である。
好ましくは、ラジカル重合は、以下の(i)~(iv)の条件下で行われる。
Component (B) is particles obtained by radical polymerization of a polyethylene oxide macromonomer and a hydrophobic monomer selected from the group consisting of acrylic acid/methacrylic acid derivative monomers and acrylamide/methacrylamide derivative monomers.
Preferably, radical polymerization is carried out under the following conditions (i) to (iv).
条件(i)
条件(i)は、「ポリエチレンオキサイドマクロモノマーの仕込みモル量:疎水性モノマーの仕込みモル量で表されるモル比が1:10~1:250であること」である。ポリエチレンオキサイドマクロモノマーの仕込みモル量:疎水性モノマー(すなわち、アクリル酸/メタクリル酸誘導体モノマーおよびアクリルアミド/メタクリルアミド誘導体モノマーの総和)の仕込みモル量で表されるモル比は、好ましくは1:10~1:200であり、より好ましくは1:25~1:100である。この範囲とすることは、コア-コロナ型粒子の形成の観点および分散安定化の観点から好ましい。
Condition (i)
Condition (i) is that "the molar ratio represented by the charged molar amount of the polyethylene oxide macromonomer and the charged molar amount of the hydrophobic monomer is 1:10 to 1:250". The molar ratio of charged molar amount of polyethylene oxide macromonomer to charged molar amount of hydrophobic monomer (that is, total sum of acrylic acid/methacrylic acid derivative monomer and acrylamide/methacrylamide derivative monomer) is preferably 1:10 to 1:200, more preferably 1:25 to 1:100. This range is preferable from the viewpoint of formation of core-corona type particles and dispersion stabilization.
条件(ii)
条件(ii)は、「ポリエチレンオキサイドマクロモノマーが式(b1)で表され、アクリル酸/メタクリル酸誘導体モノマーが式(b2)で表され、アクリルアミド/メタクリルアミド誘導体モノマーが式(b3)で表されること」である。
condition (ii)
Condition (ii) is "the polyethylene oxide macromonomer is represented by formula (b1), the acrylic acid/methacrylic acid derivative monomer is represented by formula (b2), and the acrylamide/methacrylamide derivative monomer is represented by formula (b3). Is Rukoto.
<ポリエチレンオキサイドマクロモノマー>
ポリエチレンオキサイドマクロモノマーは、好ましくは式(b1)で表される。
R11は、水素原子または炭素数1~3のアルキル基であり、
R12は、水素原子またはメチル基であり、かつ
nbは、8~200の数である)
<Polyethylene oxide macromonomer>
The polyethylene oxide macromonomer is preferably represented by formula (b1).
R 11 is a hydrogen atom or an alkyl group having 1 to 3 carbon atoms,
R 12 is a hydrogen atom or a methyl group, and nb is a number from 8 to 200)
ポリエチレンオキサイドマクロモノマーとしては、例えば、Aldrich社から市販されている市販品、あるいは日油株式会社から発売されているブレンマー(登録商標)等の市販品を用いることができる。具体的には、メトキシポリエチレングリコールモノメタクリレートであるPME-400、PME-1000、PME-4000(式(1)におけるn値がそれぞれ、n=9、n=23、n=90、全て日油株式会社製)が挙げられる。 As the polyethylene oxide macromonomer, for example, a commercially available product from Aldrich or a commercial product such as BLEMMER (registered trademark) from NOF CORPORATION can be used. Specifically, PME-400, PME-1000, and PME-4000, which are methoxypolyethylene glycol monomethacrylates (n values in formula (1) are n = 9, n = 23, n = 90, all NOF stock manufactured by the company).
<アクリル酸/メタクリル酸誘導体モノマー>
アクリル酸/メタクリル酸誘導体モノマーは、好ましくは式(b2)で表される。
R13は、水素原子または炭素数1~3のアルキル基であり、かつ
R14は、炭素数1~12のアルキル基である)
<Acrylic acid/methacrylic acid derivative monomer>
Acrylic acid/methacrylic acid derivative monomers are preferably represented by formula (b2).
R 13 is a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, and R 14 is an alkyl group having 1 to 12 carbon atoms)
アクリル酸/メタクリル酸誘導体モノマーとしては、例えば、アクリル酸メチル、アクリル酸エチル、アクリル酸プロピル、アクリル酸ブチル、アクリル酸ペンチル、アクリル酸ヘキシル、アクリル酸へプチル、アクリル酸オクチル、アクリル酸デシル、アクリル酸ドデシル、メタクリル酸メチル、メタクリル酸エチル、メタクリル酸プロピル、メタクリル酸ブチル、メタクリル酸ペンチル、メタクリル酸ヘキシル、メタクリル酸へプチル、メタクリル酸オクチル、メタクリル酸デシル、メタクリル酸ドデシル等が挙げられる。このうち、メタクリル酸メチル(メチルメタクリレート)、メタクリル酸ブチル(ブチルメタクリレート)、メタクリル酸オクチルが特に好適である。これらは、例えば、Aldrich社または東京化成社から市販されている市販品を用いることもできる。 Acrylic acid/methacrylic acid derivative monomers include, for example, methyl acrylate, ethyl acrylate, propyl acrylate, butyl acrylate, pentyl acrylate, hexyl acrylate, heptyl acrylate, octyl acrylate, decyl acrylate, acrylic dodecyl acid, methyl methacrylate, ethyl methacrylate, propyl methacrylate, butyl methacrylate, pentyl methacrylate, hexyl methacrylate, heptyl methacrylate, octyl methacrylate, decyl methacrylate, dodecyl methacrylate and the like. Among these, methyl methacrylate (methyl methacrylate), butyl methacrylate (butyl methacrylate), and octyl methacrylate are particularly preferred. Commercially available products from, for example, Aldrich Co. or Tokyo Kasei Co., Ltd. can also be used as these.
<アクリルアミド/メタクリルアミド誘導体モノマー>
アクリルアミド/メタクリルアミド誘導体モノマーは、好ましくは式(b3)で表される。
R15は、水素原子または炭素数1~3のアルキル基であり、かつ
R16およびR17は、それぞれ独立に、水素原子または炭素数1~18のアルキル基である)
<Acrylamide/methacrylamide derivative monomer>
The acrylamide/methacrylamide derivative monomer is preferably represented by formula (b3).
R 15 is a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, and R 16 and R 17 are each independently a hydrogen atom or an alkyl group having 1 to 18 carbon atoms)
アクリルアミド/メタクリルアミド誘導体モノマーとしては、例えば、t-ブチルアクリルアミド、N,N-ジメチルアクリルアミド、N-[3-(ジメチルアミノ)プロピル]アクリルアミド、t-ブチルメタクリルアミド、オクチルアクリルアミド、オクチルメタクリルアミド、オクタデシルアクリルアミド等が挙げられる。このうち、t-ブチルアクリルアミド、N,N-ジメチルアクリルアミド、N-[3-(ジメチルアミノ)プロピル]アクリルアミドが特に好適である。これらは、市販品あるいは工業用原料として入手が可能である。 Acrylamide/methacrylamide derivative monomers include, for example, t-butylacrylamide, N,N-dimethylacrylamide, N-[3-(dimethylamino)propyl]acrylamide, t-butylmethacrylamide, octylacrylamide, octylmethacrylamide, octadecyl acrylamide and the like. Among these, t-butylacrylamide, N,N-dimethylacrylamide, and N-[3-(dimethylamino)propyl]acrylamide are particularly preferred. These are available as commercial products or industrial raw materials.
本発明に用いられる疎水性モノマーは、アクリル酸/メタクリル酸誘導体モノマーおよびアクリルアミド/メタクリルアミド誘導体モノマーからなる群から選択される1種または2種以上であるが、本発明においては、疎水性モノマーとして、メチルメタクリレートおよびブチルメタクリレートの2種類、または、メチルメタクリレート、t-ブチルアクリルアミド、N,N-ジメチルアクリルアミド、およびN-[3-(ジメチルアミノ)プロピル]アクリルアミドの4種類を用いることが特に好ましい。これらの疎水性モノマーの組み合わせに、さらに、マクロモノマーとしてメトキシポリエチレングリコールモノメタクリレートを用いることが好適である。
本発明において最も好ましいマクロモノマーおよび疎水性モノマーの組み合わせとして、
・ポリエチレングリコール基の繰り返し単位が8~90、最も好ましくは15であるメトキシポリエチレングリコールモノメタクリレート、メチルメタクリレート、およびブチルメタクリレート、
・ポリエチレングリコール基の繰り返し単位が8~200、最も好ましくは90であるメトキシポリエチレングリコールモノメタクリレート、メチルメタクリレート、ブチルメタクリレート、t-ブチルアクリルアミド、N,N-ジメチルアクリルアミド、およびN-[3-(ジメチルアミノ)プロピル]アクリルアミド、t-ブチルメタクリルアミド、オクチルアクリルアミド、オクチルメタクリルアミド、オクタデシルアクリルアミドが挙げられる。
The hydrophobic monomer used in the present invention is one or more selected from the group consisting of acrylic acid/methacrylic acid derivative monomers and acrylamide/methacrylamide derivative monomers. , methyl methacrylate and butyl methacrylate, or four of methyl methacrylate, t-butylacrylamide, N,N-dimethylacrylamide and N-[3-(dimethylamino)propyl]acrylamide. In addition to the combination of these hydrophobic monomers, it is preferred to use methoxypolyethylene glycol monomethacrylate as macromonomer.
As the most preferred combination of macromonomers and hydrophobic monomers in the present invention,
- methoxy polyethylene glycol monomethacrylate, methyl methacrylate, and butyl methacrylate in which the polyethylene glycol group has 8 to 90 repeating units, most preferably 15;
- Methoxypolyethylene glycol monomethacrylate, methyl methacrylate, butyl methacrylate, t-butylacrylamide, N,N-dimethylacrylamide, and N-[3-(dimethyl) having a polyethylene glycol group with repeating units of 8 to 200, most preferably 90 amino)propyl]acrylamide, t-butylmethacrylamide, octylacrylamide, octylmethacrylamide, octadecylacrylamide.
条件(iii)
条件(iii)は、「重合溶媒が水-アルコール混合溶媒であり、アルコールがエタノール、ジプロピレングリコール、1,3-ブチレングリコール、およびイソプレングリコールからなる群から選択されること」である。
condition (iii)
Condition (iii) is that "the polymerization solvent is a water-alcohol mixed solvent, and the alcohol is selected from the group consisting of ethanol, dipropylene glycol, 1,3-butylene glycol, and isoprene glycol".
条件(iv)
条件(iv)は、「水-アルコール混合溶媒の溶媒組成が、20℃で、質量比で、水:アルコール=90~10:10~90であること」である。好ましくは、水:アルコール=80~20:20~80である。この範囲であることは、疎水性モノマーの溶解能が低くなり過ぎず、ミクロ粒子の生成の観点から好ましく、また、疎水性相互作用による疎水性モノマーのエマルションが生成し、乳化重合が進行してミクロ粒子がより得られることから好ましい。
Condition (iv)
Condition (iv) is that "the solvent composition of the water-alcohol mixed solvent is water:alcohol=90-10:10-90 at 20° C. in mass ratio". Preferably, the water:alcohol ratio is 80-20:20-80. Within this range, the dissolving ability of the hydrophobic monomer does not become too low, which is preferable from the viewpoint of the generation of microparticles. It is preferable because more microparticles are obtained.
ラジカル重合は、架橋性モノマーの存在下または非存在下で行うことができる。
好ましい一形態において、ラジカル重合の条件が、さらに下記(v)の条件を含む。
Radical polymerization can be carried out in the presence or absence of crosslinkable monomers.
In a preferred embodiment, the radical polymerization conditions further include the following conditions (v).
条件(v)
条件(v)は、「ラジカル重合が、架橋性モノマーの存在下に行われ、架橋性モノマーの仕込み量が、疎水性モノマーの仕込み量に対して、1.5質量%以下であること」である。
<架橋性モノマー>
架橋性モノマーは疎水性であることが好ましい。具体的には、Aldrich社から発売されているエチレングリコールジメタクリレート(以下、EGDMAと略すことがある)、日油社から発売されているブレンマー(登録商標)PDE-50等を用いることができる。
より好ましくは、架橋性モノマーは式(b4)で表される。
R18およびR19は、それぞれ独立に、炭素数1~3のアルキル基であり、
mbは、1~3の数である)
Condition (v)
The condition (v) is that "radical polymerization is carried out in the presence of a crosslinkable monomer, and the amount of the crosslinkable monomer charged is 1.5% by mass or less with respect to the amount of the hydrophobic monomer charged." be.
<Crosslinking monomer>
Preferably, the cross-linking monomer is hydrophobic. Specifically, ethylene glycol dimethacrylate (hereinafter sometimes abbreviated as EGDMA) sold by Aldrich, Blemmer (registered trademark) PDE-50 sold by NOF, and the like can be used.
More preferably, the crosslinkable monomer is represented by formula (b4).
R 18 and R 19 are each independently an alkyl group having 1 to 3 carbon atoms,
mb is a number from 1 to 3)
(B)成分は、好ましくは、(アクリルアミド/アクリル酸DMAPA/メタクリル酸メトキシPEG)コポリマーまたは(アクリレーツ/メタクリル酸メトキシPEG-90)クロスポリマーである。 The (B) component is preferably an (acrylamide/DMAPA acrylate/methoxy PEG methacrylate) copolymer or an (acrylates/methoxy PEG-90 methacrylate) crosspolymer.
(B)成分は、1種または2種以上を配合することができる。(B)成分の配合量は、化粧料の総量に対して、好ましくは0.05~3質量%であり、より好ましくは0.1~1.5質量%である。 The component (B) can be blended either alone or in combination of two or more. The blending amount of component (B) is preferably 0.05 to 3% by mass, more preferably 0.1 to 1.5% by mass, based on the total amount of the cosmetic.
(C)油分
本発明による化粧料は、(C)油分を含んでなる。(C)成分としては、例えば、エステル油、シリコーン油、炭化水素油、高級脂肪酸、高級アルコール、液体油、固体油、半固形油等が挙げられ、好ましくは炭化水素油、シリコーン油、およびエステル油からなる群から選ばれる。
(C) Oil The cosmetic according to the present invention comprises (C) oil. Component (C) includes, for example, ester oils, silicone oils, hydrocarbon oils, higher fatty acids, higher alcohols, liquid oils, solid oils, semi-solid oils and the like, preferably hydrocarbon oils, silicone oils and ester oils. selected from the group consisting of oils;
エステル油としては、例えば、オクタン酸オクチル、ノナン酸ノニル、オクタン酸セチル、ミリスチン酸イソプロピル、ミリスチン酸オクチルドデシル、パルミチン酸イソプロピル、パルミチン酸エチルヘキシル、ステアリン酸ブチル、ラウリン酸ヘキシル、ミリスチン酸ミリスチル、オレイン酸デシル、ジメチルオクタン酸ヘキシルデシル、乳酸セチル、乳酸ミリスチル、酢酸ラノリン、ステアリン酸イソセチル、イソステアリン酸イソセチル、12-ヒドロキシステアリン酸コレステリル、ジ-2-エチルヘキサン酸エチレングリコール、ジペンタエリスリトール脂肪酸エステル、モノイソステアリン酸N-アルキルグリコール、ジカプリン酸ネオペンチルグリコール、ピバリン酸トリプロピレングリコール、リンゴ酸ジイソステアリル、ジ-2-ヘプチルウンデカン酸グリセリル、ジイソステアリン酸グリセリル、トリ-2-エチルヘキサン酸トリメチロールプロパン、トリイソステアリン酸トリメチロールプロパン、テトラエチルヘキサン酸ペンタエリスリチル、トリ-2-エチルヘキサン酸グリセリル(トリエチルヘキサノイン)、トリオクタン酸グリセリル、トリイソパルミチン酸グリセリル、トリイソステアリン酸トリメチロールプロパン、セチル2-エチルヘキサノエート-2-エチルヘキシルパルミテート、トリミリスチン酸グリセリル、トリ-2-ヘプチルウンデカン酸グリセライド、ヒマシ油脂肪酸メチルエステル、オレイン酸オレイル、アセトグリセライド、パルミチン酸2-ヘプチルウンデシル、アジピン酸ジイソブチル、N-ラウロイル-L-グルタミン酸-2-オクチルドデシルエステル、アジピン酸ジ-2-ヘプチルウンデシル、エチルラウレート、セバシン酸ジ-2-エチルヘキシル、ミリスチン酸2-ヘキシルデシル、パルミチン酸2-ヘキシルデシル、アジピン酸2-ヘキシルデシル、セバシン酸ジイソプロピル、コハク酸2-エチルヘキシル、クエン酸トリエチル、エチルヘキサン酸セチル、マカデミアナッツ脂肪酸フィトステリル等が挙げられる。 Examples of ester oils include octyl octanoate, nonyl nonanoate, cetyl octanoate, isopropyl myristate, octyldodecyl myristate, isopropyl palmitate, ethylhexyl palmitate, butyl stearate, hexyl laurate, myristyl myristate, and oleic acid. Decyl, hexyldecyl dimethyloctanoate, cetyl lactate, myristyl lactate, lanolin acetate, isocetyl stearate, isocetyl isostearate, cholesteryl 12-hydroxystearate, ethylene glycol di-2-ethylhexanoate, dipentaerythritol fatty acid ester, monoisostearin Acid N-alkyl glycol, neopentyl glycol dicaprate, tripropylene glycol pivalate, diisostearyl malate, glyceryl di-2-heptylundecanoate, glyceryl diisostearate, trimethylolpropane tri-2-ethylhexanoate, triisostearin trimethylolpropane acid, pentaerythrityl tetraethylhexanoate, glyceryl tri-2-ethylhexanoate (triethylhexanoin), glyceryl trioctanoate, glyceryl triisopalmitate, trimethylolpropane triisostearate, cetyl 2-ethylhexanoate -2-ethylhexyl palmitate, glyceryl trimyristate, tri-2-heptylundecanoic acid glyceride, castor oil fatty acid methyl ester, oleyl oleate, acetoglyceride, 2-heptylundecyl palmitate, diisobutyl adipate, N-lauroyl- L-glutamic acid 2-octyldodecyl ester, di-2-heptylundecyl adipate, ethyl laurate, di-2-ethylhexyl sebacate, 2-hexyldecyl myristate, 2-hexyldecyl palmitate, 2-adipate Hexyldecyl, diisopropyl sebacate, 2-ethylhexyl succinate, triethyl citrate, cetyl ethylhexanoate, macadamia nut fatty acid phytosteryl and the like.
シリコーン油としては、例えば、鎖状ポリシロキサン(例えば、ジメチコン、ジフェニルシロキシフェニルトリメチコン、ジフェニルポリシロキサン等)、環状ポリシロキサン(例えば、オクタメチルシクロテトラシロキサン、デカメチルシクロペンタシロキサン、ドデカメチルシクロヘキサシロキサン等)、3次元網目構造を形成しているシリコーン樹脂、シリコーンゴム、各種変性ポリシロキサン(アミノ変性ポリシロキサン、ポリエーテル変性ポリシロキサン、アルキル変性ポリシロキサン、フッ素変性ポリシロキサン等)、アクリルシリコーン類等が挙げられ、好ましくは鎖状ポリシロキサンである。 Examples of silicone oils include linear polysiloxanes (e.g., dimethicone, diphenylsiloxyphenyl trimethicone, diphenylpolysiloxane, etc.), cyclic polysiloxanes (e.g., octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexasiloxane, siloxane, etc.), silicone resins that form a three-dimensional network structure, silicone rubber, various modified polysiloxanes (amino-modified polysiloxane, polyether-modified polysiloxane, alkyl-modified polysiloxane, fluorine-modified polysiloxane, etc.), acrylic silicones etc., preferably chain polysiloxane.
炭化水素油としては、例えば、イソドデカン、イソヘキサデカン、イソパラフィン、ミネラルオイル(流動パラフィン)、オゾケライト、スクワラン、プリスタン、パラフィン、セレシン、スクワレン、ワセリン、マイクロクリスタリンワックス、水添ポリデセン等が挙げられる。 Examples of hydrocarbon oils include isododecane, isohexadecane, isoparaffin, mineral oil (liquid paraffin), ozokerite, squalane, pristane, paraffin, ceresin, squalene, petrolatum, microcrystalline wax, and hydrogenated polydecene.
高級脂肪酸としては、例えば、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘン酸、オレイン酸、ウンデシレン酸、トール酸、イソステアリン酸、リノール酸、リノレイン酸、エイコサペンタエン酸(EPA)、ドコサヘキサエン酸(DHA)等が挙げられる。 Examples of higher fatty acids include lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, oleic acid, undecylenic acid, toric acid, isostearic acid, linoleic acid, linoleic acid, eicosapentaenoic acid (EPA), docosahexaenoic acid ( DHA) and the like.
高級アルコールとしては、例えば、直鎖アルコール(例えば、ラウリルアルコール、セチルアルコール、ステアリルアルコール、ベヘニルアルコール、ミリスチルアルコール、オレイルアルコール、セトステアリルアルコール等)、分枝鎖アルコール(例えば、ラノリンアルコール、コレステロール、フィトステロール、ヘキシルドデカノール、イソステアリルアルコール、オクチルドデカノール等)等が挙げられる。 Higher alcohols include, for example, straight-chain alcohols (eg, lauryl alcohol, cetyl alcohol, stearyl alcohol, behenyl alcohol, myristyl alcohol, oleyl alcohol, cetostearyl alcohol, etc.), branched-chain alcohols (eg, lanolin alcohol, cholesterol, phytosterol, hexyldodecanol, isostearyl alcohol, octyldodecanol, etc.).
液体油としては、例えば、アボガド油、ツバキ油、マカデミアナッツ油、トウモロコシ油、オリーブ油、ナタネ油、ゴマ油、パーシック油、小麦胚芽油、サザンカ油、ヒマシ油、アマニ油、サフラワー油、綿実油、エノ油、大豆油、落花生油、茶実油、カヤ油、コメヌカ油、シナギリ油、日本キリ油、ホホバ油、胚芽油、トリグリセリン等が挙げられる。固体油としては、例えば、カカオ脂、ヤシ油、硬化ヤシ油、パーム油、パーム核油、水添パーム油、モクロウ核油、硬化油、モクロウ、硬化ヒマシ油等が挙げられる。半固形油としては、例えば、シア脂、部分水添ヤシ油、部分水添ホホバ油等が挙げられる。 Liquid oils include, for example, avocado oil, camellia oil, macadamia nut oil, corn oil, olive oil, rapeseed oil, sesame oil, persic oil, wheat germ oil, sasanqua oil, castor oil, linseed oil, safflower oil, cottonseed oil, and eno oil. , soybean oil, peanut oil, tea seed oil, kaya oil, rice bran oil, sinagiri oil, Japanese pear oil, jojoba oil, germ oil, triglycerin and the like. Examples of solid oils include cacao butter, coconut oil, hydrogenated coconut oil, palm oil, palm kernel oil, hydrogenated palm oil, Japanese wax kernel oil, hydrogenated oil, Japanese wax, and hydrogenated castor oil. Semi-solid oils include, for example, shea butter, partially hydrogenated coconut oil, partially hydrogenated jojoba oil, and the like.
(C)成分は、1種または2種以上を配合することができる。(C)成分の配合量は、化粧料の総量に対して、好ましくは0.5~30質量%であり、より好ましくは1~15質量%である。 (C) component can be blended one or two or more. The blending amount of component (C) is preferably 0.5 to 30% by mass, more preferably 1 to 15% by mass, based on the total amount of the cosmetic.
(D)水
本発明による化粧料は、(D)水を含んでなる。水としては、化粧品、医薬部外品等に使用される水を使用することができ、例えば、精製水、イオン交換水、水道水等を使用することができる。
水の配合量は、本発明による化粧料の総量に対して、好ましくは30~95質量%であり、より好ましくは60~90質量%である。
(D) Water The cosmetic according to the present invention contains (D) water. As water, water used in cosmetics, quasi-drugs, etc. can be used, and for example, purified water, ion-exchanged water, tap water, etc. can be used.
The amount of water to be blended is preferably 30-95% by mass, more preferably 60-90% by mass, based on the total amount of the cosmetic composition according to the present invention.
本発明による化粧料は、界面活性剤をさらに含むことができる。界面活性剤としては、両性界面活性剤、カチオン界面活性剤、ノニオン界面活性剤、およびアニオン界面活性剤が挙げられ、好ましくはノニオン界面活性剤である。一方、使用性の観点から、界面活性剤の配合量は、化粧料の総量に対して、好ましくは1質量%以下であり、より好ましくは0.5質量%以下であり、よりさらに好ましくは0.2質量%以下、特に好ましくは0.1質量%以下である。界面活性剤を含まないこと(0質量%)も本発明の好ましい一形態である。 The cosmetic according to the present invention can further contain a surfactant. Surfactants include amphoteric surfactants, cationic surfactants, nonionic surfactants, and anionic surfactants, preferably nonionic surfactants. On the other hand, from the viewpoint of usability, the blending amount of the surfactant is preferably 1% by mass or less, more preferably 0.5% by mass or less, and even more preferably 0% by mass, relative to the total amount of the cosmetic. 0.2% by mass or less, particularly preferably 0.1% by mass or less. Not containing a surfactant (0% by mass) is also a preferred embodiment of the present invention.
本発明による化粧料には、上記成分の他、通常化粧品や医薬品に用いられる任意成分を配合することができる。任意成分としては例えば、低級アルコール、保湿剤、増粘剤、金属イオン封鎖剤、中和剤、pH調整剤、酸化防止剤、防腐剤、薬剤等、通常化粧品に用いられる他の成分の配合が可能であり、本発明の効果を奏する限り、一種または二種以上を配合することができる。 In addition to the above ingredients, the cosmetics according to the present invention can contain optional ingredients that are usually used in cosmetics and pharmaceuticals. Optional ingredients include other ingredients commonly used in cosmetics, such as lower alcohols, humectants, thickeners, sequestering agents, neutralizers, pH adjusters, antioxidants, preservatives, and drugs. As long as it is possible and the effects of the present invention are exhibited, one or more of them can be blended.
低級アルコールとしては、例えば、エタノール、1-プロパノール、2-プロパノール、イソブチルアルコール、t-ブチルアルコール等が挙げられる。 Examples of lower alcohols include ethanol, 1-propanol, 2-propanol, isobutyl alcohol, t-butyl alcohol and the like.
保湿剤としては、例えば、ポリエチレングリコール、プロピレングリコール、グリセリン、1,3-ブチレングリコール(BG)、エリスリトール、キシリトール、ソルビトール、マルチトール、コンドロイチン硫酸、ヒアルロン酸、ムコイチン硫酸、カロニン酸、アテロコラーゲン、コレステリル-12-ヒドロキシステアレート、乳酸ナトリウム、胆汁酸塩、dl-ピロリドンカルボン酸塩、短鎖可溶性コラーゲン、イザヨイバラ抽出物、セイヨウノコギリソウ抽出物、メリロート抽出物等が挙げられる。 Examples of moisturizing agents include polyethylene glycol, propylene glycol, glycerin, 1,3-butylene glycol (BG), erythritol, xylitol, sorbitol, maltitol, chondroitin sulfate, hyaluronic acid, mucoitin sulfate, caronin acid, atelocollagen, cholesteryl- 12-hydroxystearate, sodium lactate, bile salts, dl-pyrrolidone carboxylate, short-chain soluble collagen, rose rose extract, yarrow extract, melilot extract and the like.
増粘剤としては、例えば、アラビアガム、カラギーナン、カラヤガム、トラガカントガム、キャロブガム、クインスシード(マルメロ)、カゼイン、デキストリン、ゼラチン、ペクチン酸ナトリウム、アラギン酸ナトリウム、メチルセルロース、エチルセルロース、CMC、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース、PVA、PVM、PVP、ポリアクリル酸ナトリウム、カルボキシビニルポリマー(カルボマー)、(ジメチルアクリルアミド/アクリロイルジメチルタウリンNa)クロスポリマー、(アクリロイルジメチルタウリンアンモニウム/VP)コポリマー、(アクリロイルジメチルタウリンアンモニウムメタクリル酸べへネス-25)クロスポリマー、(アクリル酸Na/アクリロイルジメチルタウリンNa)コポリマー、ローカストビーンガム、グアガム、タマリントガム、ジアルキルジメチルアンモニウム硫酸セルロース、キサンタンガム、ケイ酸アルミニウムマグネシウム、ベントナイト、ヘクトライト、ケイ酸A1Mg(ビーガム)、ラポナイト、無水ケイ酸等が挙げられる。 Thickeners include, for example, gum arabic, carrageenan, karaya gum, tragacanth gum, carob gum, quince seed (quince), casein, dextrin, gelatin, sodium pectate, sodium araginate, methylcellulose, ethylcellulose, CMC, hydroxyethylcellulose, hydroxypropyl Cellulose, PVA, PVM, PVP, sodium polyacrylate, carboxyvinyl polymer (carbomer), (dimethylacrylamide/acryloyldimethyltaurate Na) crosspolymer, (acryloyldimethyltaurate ammonium/VP) copolymer, (acryloyldimethyltaurate ammonium methacrylate) Henneth-25) Crosspolymer, (Na acrylate/Na acryloyldimethyltaurate) copolymer, locust bean gum, guar gum, tamarind gum, dialkyldimethylammonium cellulose sulfate, xanthan gum, magnesium aluminum silicate, bentonite, hectorite, A1 Mg silicate ( Veegum), laponite, silicic anhydride, and the like.
金属イオン封鎖剤としては、例えば、1-ヒドロキシエタン-1,1-ジフォスホン酸、1-ヒドロキシエタン-1,1-ジフォスホン酸四ナトリウム塩、エデト酸二ナトリウム(EDTA-2Na)、エデト酸三ナトリウム、エデト酸四ナトリウム、クエン酸ナトリウム、ポリリン酸ナトリウム、メタリン酸ナトリウム、グルコン酸、リン酸、クエン酸、コハク酸、エデト酸、エチレンジアミンヒドロキシエチル三酢酸3ナトリウム等が挙げられる。 Examples of sequestering agents include 1-hydroxyethane-1,1-diphosphonic acid, tetrasodium 1-hydroxyethane-1,1-diphosphonic acid, disodium edetate (EDTA-2Na), and trisodium edetate. , tetrasodium edetate, sodium citrate, sodium polyphosphate, sodium metaphosphate, gluconic acid, phosphoric acid, citric acid, succinic acid, edetic acid, trisodium ethylenediaminehydroxyethyl triacetate, and the like.
中和剤としては、例えば、2-アミノ-2-メチル-1-プロパノール、2-アミノ-2-メチル-1,3-プロパンジオール、水酸化カリウム、水酸化ナトリウム、トリエタノールアミン、炭酸ナトリウム等が挙げられる。 Examples of neutralizing agents include 2-amino-2-methyl-1-propanol, 2-amino-2-methyl-1,3-propanediol, potassium hydroxide, sodium hydroxide, triethanolamine, sodium carbonate, and the like. are mentioned.
pH調製剤としては、例えば、乳酸-乳酸ナトリウム、クエン酸-クエン酸ナトリウム、コハク酸-コハク酸ナトリウム等の緩衝剤等が挙げられる。
酸化防止剤としては、例えば、ジブチルヒドロキシトルエン、ブチルヒドロキシアニソール、ピロ亜硫酸ナトリウム、没食子酸エステル類等が挙げられる。
防腐剤としては、例えば、メチルパラベン、エチルパラベン、ブチルパラベン等のパラオキシ安息香酸エステル類、安息香酸、サリチル酸、ソルビン酸、パラクロルメタクレゾール、ヘキサクロロフェン、塩化ベンザルコニウム、塩化クロルヘキシジン、トリクロロカルバニリド、感光素、フェノキシエタノール等が挙げられる。
Examples of pH adjusters include buffers such as lactic acid-sodium lactate, citric acid-sodium citrate, and succinic acid-sodium succinate.
Examples of antioxidants include dibutylhydroxytoluene, butylhydroxyanisole, sodium pyrosulfite, and gallic acid esters.
Examples of antiseptics include paraoxybenzoic acid esters such as methylparaben, ethylparaben, and butylparaben, benzoic acid, salicylic acid, sorbic acid, parachlorometacresol, hexachlorophene, benzalkonium chloride, chlorhexidine chloride, and trichlorocarbanilide. , a photosensitive element, phenoxyethanol, and the like.
薬剤としては、例えば、アスコルビン酸(ビタミンC)、トラネキサム酸、コウジ酸、エラグ酸、アルブチン、アルコキシサリチル酸、グリチルリチン酸、トコフェロール、レチノール、およびこれらの塩または誘導体(例えば、L-アスコルビン酸ナトリウム、L-アスコルビン酸エステルマグネシウム塩、L-アスコルビン酸グルコシド、2-O-エチル-L-アスコルビン酸、3-O-エチル-L-アスコルビン酸、4-メトキシサリチル酸ナトリウム塩、4-メトキシサリチル酸カリウム塩、グリチルリチン酸ジカリウム、グリチルリチン酸ステアリル、酢酸トコフェロール、酢酸レチノール、パルミチン酸レチノール等)、ニコチン酸またはおよびその誘導体(例えば、ニコチン酸アミド)、カフェイン、タンニン、ベラパミルおよびその誘導体、甘草抽出物、グラブリジン、火棘の果実の熱水抽出物、各種生薬、加水分解シルク、加水分解コンキオリン、チャエキス、トルメンチラ根エキス、アシタバ葉/茎エキス、アロエベラ葉エキス、サクラ葉エキス、トウキ根エキス、シイクワシャー果皮エキス、イリス根エキス、トゲキリンサイ/ヒヂリメン/ミツイシコンブ/ウスバアオノリ/ワカメエキス、ガマ穂エキス、ヒキオコシ葉/茎エキス、ツバキ種子エキス、ミツイシコンブ/ワカメエキス、ミシマサイコ根エキス、オランダガラシ葉/茎エキス、カシア樹皮エキス、ローズマリー葉油、ラベンダー油、グルタミン酸、トリメチルグリシン、クロルフェネシン、メントキシプロパンジオール等が挙げられる。 Examples of drugs include ascorbic acid (vitamin C), tranexamic acid, kojic acid, ellagic acid, arbutin, alkoxysalicylic acid, glycyrrhizic acid, tocopherol, retinol, and salts or derivatives thereof (e.g., sodium L-ascorbate, L -ascorbic acid ester magnesium salt, L-ascorbic acid glucoside, 2-O-ethyl-L-ascorbic acid, 3-O-ethyl-L-ascorbic acid, 4-methoxysalicylic acid sodium salt, 4-methoxysalicylic acid potassium salt, glycyrrhizin dipotassium acid, stearyl glycyrrhizinate, tocopherol acetate, retinol acetate, retinol palmitate, etc.), nicotinic acid or its derivatives (e.g. nicotinamide), caffeine, tannins, verapamil and its derivatives, licorice extract, glabridin, fire Hot water extract of thorn fruit, various crude drugs, hydrolyzed silk, hydrolyzed conchiolin, tea extract, tormentilla root extract, Angelica keiskei leaf/stem extract, aloe vera leaf extract, cherry leaf extract, angelica root extract, shiikuwasha pericarp extract, iris root extract, thorny rhinoceros / hijirimen / honey kelp / blue laver / wakame seaweed extract, cattail extract, hikiokoshi leaf / stem extract, camellia seed extract, honey kelp / wakame extract, honeysuckle root extract, Dutch mustard leaf / stem extract, cassia bark extract, rose Marie leaf oil, lavender oil, glutamic acid, trimethylglycine, chlorphenesin, menthoxypropanediol and the like.
その他、紫外線吸収剤、香料等も適宜配合することができる。 In addition, UV absorbers, fragrances, etc. can be added as appropriate.
本発明による化粧料の製造方法は、特に限定されるものではなく、常法に従って製造することができる。 The method for producing the cosmetic according to the present invention is not particularly limited, and it can be produced according to a conventional method.
本発明による化粧料としては、例えば、スキンケア化粧料(例えば、化粧水、乳液、クリーム、美容液、パック、マスク等)、メーキャップ化粧料(例えば、ファンデーション、化粧下地等)、皮膚洗浄料(例えば、洗顔料、メイク落とし等)、日焼け止め化粧料、軟膏等が挙げられる。なお、これらの形態は例示に過ぎず、本発明にかかる化粧料はこれらの形態に限定されるものではない。 Cosmetics according to the present invention include, for example, skin care cosmetics (e.g. lotions, milky lotions, creams, serums, packs, masks, etc.), makeup cosmetics (e.g., foundations, makeup bases, etc.), skin cleansers (e.g. , face wash, makeup remover, etc.), sunscreen cosmetics, ointments, and the like. These forms are merely examples, and the cosmetic according to the present invention is not limited to these forms.
以下の例に基づいて本発明を具体的に説明するが、本発明はこれらの例に限定されるものではない。含有量は特記しない限り、総量に対する質量%で示す。 The present invention will be specifically described based on the following examples, but the present invention is not limited to these examples. Unless otherwise specified, the content is shown in % by mass with respect to the total amount.
[実施例1~8および比較例1~3]
表1に示される配合で、実施例1~8および比較例1~3の化粧料を調製した。表中の数値は質量%を示す。
得られた化粧料の粘度は表1のとおりである。粘度はB型粘度計(30℃)で測定した。
Cosmetics of Examples 1 to 8 and Comparative Examples 1 to 3 were prepared with the formulations shown in Table 1. Numerical values in the table indicate % by mass.
The viscosities of the obtained cosmetics are shown in Table 1. Viscosity was measured with a Brookfield viscometer (30°C).
[安定性評価]
上記で調製した化粧料を、調製直後に、目視および光学顕微鏡によって観察し、以下の基準にしたがって、安定性を評価した。得られた結果は、表1のとおりである。
〇:目視では油分の分離が確認されず、光学顕微鏡では乳化粒子の顕著な合一、肥大が確認されない。
×:目視で油分の分離が確認され、光学顕微鏡では乳化粒子の顕著な合一、肥大が確認される。
[Stability evaluation]
Immediately after preparation, the cosmetics prepared above were observed visually and with an optical microscope, and their stability was evaluated according to the following criteria. The obtained results are shown in Table 1.
◯: Separation of oil is not confirmed by visual observation, and remarkable coalescence and enlargement of emulsified particles are not confirmed by optical microscopy.
x: Separation of oil is visually observed, and remarkable coalescence and enlargement of emulsified particles are observed with an optical microscope.
[使用性評価]
上記で調製した化粧料を、専門パネル5名が肌に塗布して、塗布中の「みずみずしさ」について評価した。各専門パネルの評価をもとに、以下の基準に従って評価した。得られた結果は表1のとおりである。
A:パネル5名中4名以上がみずみずしい感触があると回答した。
B:パネル5名中3名がみずみずしい感触があると回答した。
C:パネル5名中2名がみずみずしい感触があると回答した。
D:パネル5名中1名がみずみずしい感触があると回答した。
E:パネル5名中全員がみずみずしい感触に欠けると回答した。
[Usability evaluation]
The cosmetic preparations prepared above were applied to the skin by 5 expert panelists, and "freshness" during application was evaluated. Based on the evaluation of each specialized panel, evaluation was made according to the following criteria. The results obtained are shown in Table 1.
A: Four or more of the five panelists answered that they had a fresh touch.
B: Three out of five panelists answered that they had a fresh feeling.
C: Two out of five panelists answered that they had a fresh feeling.
D: One of the five panelists answered that it had a fresh touch.
E: All of the five panelists answered that they lacked a fresh feel.
[処方例1~7]
以下の表2~8に本発明の化粧料の処方例1~7を示す。表中の数値は質量%を示す。
Formulation Examples 1 to 7 of the cosmetic of the present invention are shown in Tables 2 to 8 below. Numerical values in the table indicate % by mass.
Claims (10)
R1は、水酸基で置換されていてもよい炭素数1~6の炭化水素基、または水素原子であり、
Xは、-CH2-または-N(R2)-であり、ここで、R2は、水酸基で置換されていてもよい炭素数1~6の炭化水素基、または水素原子であり、かつ
naは、1~3の整数である)、
(B)コア-コロナ型粒子、
(C)油分、および
(D)水
を含んでなり、
(B)コア-コロナ型粒子が、ポリエチレンオキサイドマクロモノマーと、アクリル酸/メタクリル酸誘導体モノマーおよびアクリルアミド/メタクリルアミド誘導体モノマーからなる群から選択される疎水性モノマーとをラジカル重合して得られる粒子である、水中油型乳化化粧料。 (A) a cyclic carboxamide derivative represented by formula (a) or a salt thereof
R 1 is a hydrocarbon group having 1 to 6 carbon atoms which may be substituted with a hydroxyl group, or a hydrogen atom,
X is —CH 2 — or —N(R 2 )—, wherein R 2 is a hydrocarbon group having 1 to 6 carbon atoms which may be substituted with a hydroxyl group, or a hydrogen atom, and na is an integer of 1 to 3),
(B) core-corona particles;
(C) oil, and (D) water,
(B) The core-corona type particles are particles obtained by radically polymerizing a polyethylene oxide macromonomer and a hydrophobic monomer selected from the group consisting of acrylic acid/methacrylic acid derivative monomers and acrylamide/methacrylamide derivative monomers. There is an oil-in-water emulsified cosmetic.
R1が、炭素数1~3のヒドロキシアルキル基であり、
Xが、-CH2-または-NH-であり、かつ
naが、1である、請求項1に記載の化粧料。 (A) In the formula (a) of the component,
R 1 is a hydroxyalkyl group having 1 to 3 carbon atoms,
2. The cosmetic according to claim 1, wherein X is -CH 2 - or -NH- and na is 1.
(i)前記ポリエチレンオキサイドマクロモノマーの仕込みモル量:前記疎水性モノマーの仕込みモル量で表されるモル比が1:10~1:250であること、
(ii)前記ポリエチレンオキサイドマクロモノマーが式(b1)で表され、前記アクリル酸/メタクリル酸誘導体モノマーが式(b2)で表され、前記アクリルアミド/メタクリルアミド誘導体モノマーが式(b3)で表されること、
(iii)重合溶媒が水-アルコール混合溶媒であり、前記アルコールがエタノール、ジプロピレングリコール、1,3-ブチレングリコール、およびイソプレングリコールからなる群から選択されること、および
(iv)前記水-アルコール混合溶媒の溶媒組成が、20℃で、質量比で、水:アルコール=90~10:10~90であること。
R11は、水素原子または炭素数1~3のアルキル基であり、
R12は、水素原子またはメチル基であり、かつ
nbは、8~200の数である)
R13は、水素原子または炭素数1~3のアルキル基であり、かつ
R14は、炭素数1~12のアルキル基である)
R15は、水素原子または炭素数1~3のアルキル基であり、かつ
R16およびR17は、それぞれ独立に、水素原子または炭素数1~18のアルキル基である) The cosmetic according to claim 1 or 2, wherein the radical polymerization is performed under the following conditions (i) to (iv):
(i) the molar ratio of the charged molar amount of the polyethylene oxide macromonomer to the charged molar amount of the hydrophobic monomer is 1:10 to 1:250;
(ii) the polyethylene oxide macromonomer is represented by formula (b1), the acrylic acid/methacrylic acid derivative monomer is represented by formula (b2), and the acrylamide/methacrylamide derivative monomer is represented by formula (b3). matter,
(iii) the polymerization solvent is a water-alcohol mixed solvent, and said alcohol is selected from the group consisting of ethanol, dipropylene glycol, 1,3-butylene glycol, and isoprene glycol; and (iv) said water-alcohol. The solvent composition of the mixed solvent is water:alcohol=90-10:10-90 at 20.degree.
R 11 is a hydrogen atom or an alkyl group having 1 to 3 carbon atoms,
R 12 is a hydrogen atom or a methyl group, and nb is a number from 8 to 200)
R 13 is a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, and R 14 is an alkyl group having 1 to 12 carbon atoms)
R 15 is a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, and R 16 and R 17 are each independently a hydrogen atom or an alkyl group having 1 to 18 carbon atoms)
(v)前記ラジカル重合が、架橋性モノマーの存在下に行われ、前記架橋性モノマーの仕込み量が、前記疎水性モノマーの仕込み量に対して、1.5質量%以下であること。 6. The cosmetic according to claim 5, wherein the radical polymerization conditions further comprise the following conditions (v):
(v) The radical polymerization is carried out in the presence of a crosslinkable monomer, and the charge amount of the crosslinkable monomer is 1.5 mass % or less with respect to the charge amount of the hydrophobic monomer.
R18およびR19は、それぞれ独立に、炭素数1~3のアルキル基であり、
mbは、1~3の数である) 7. The cosmetic according to claim 6, wherein the crosslinkable monomer is represented by formula (b4).
R 18 and R 19 are each independently an alkyl group having 1 to 3 carbon atoms,
mb is a number from 1 to 3)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202280076891.1A CN118265517A (en) | 2021-12-20 | 2022-12-07 | Oil-in-water emulsion cosmetics |
| JP2023569277A JPWO2023120180A1 (en) | 2021-12-20 | 2022-12-07 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021-206140 | 2021-12-20 | ||
| JP2021206140 | 2021-12-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2023120180A1 true WO2023120180A1 (en) | 2023-06-29 |
Family
ID=86902255
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2022/045021 Ceased WO2023120180A1 (en) | 2021-12-20 | 2022-12-07 | Oil-in-water type emulsified cosmetic |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JPWO2023120180A1 (en) |
| CN (1) | CN118265517A (en) |
| WO (1) | WO2023120180A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025142558A1 (en) * | 2023-12-28 | 2025-07-03 | 株式会社 資生堂 | Cosmetic containing pyridoxine |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011040496A1 (en) * | 2009-09-30 | 2011-04-07 | 株式会社資生堂 | Heparanase activity inhibitor |
| JP2018168087A (en) * | 2017-03-29 | 2018-11-01 | 株式会社 資生堂 | Oil-in-water cosmetics |
| WO2019182126A1 (en) * | 2018-03-23 | 2019-09-26 | 株式会社 資生堂 | Core-corona polymer particles |
| JP2020176085A (en) * | 2019-04-17 | 2020-10-29 | ポーラ化成工業株式会社 | Wrinkle ameliorating composition |
| US20200399481A1 (en) * | 2018-01-08 | 2020-12-24 | The University Of Sussex | Pickering emulsions |
-
2022
- 2022-12-07 JP JP2023569277A patent/JPWO2023120180A1/ja active Pending
- 2022-12-07 CN CN202280076891.1A patent/CN118265517A/en active Pending
- 2022-12-07 WO PCT/JP2022/045021 patent/WO2023120180A1/en not_active Ceased
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011040496A1 (en) * | 2009-09-30 | 2011-04-07 | 株式会社資生堂 | Heparanase activity inhibitor |
| JP2018168087A (en) * | 2017-03-29 | 2018-11-01 | 株式会社 資生堂 | Oil-in-water cosmetics |
| US20200399481A1 (en) * | 2018-01-08 | 2020-12-24 | The University Of Sussex | Pickering emulsions |
| WO2019182126A1 (en) * | 2018-03-23 | 2019-09-26 | 株式会社 資生堂 | Core-corona polymer particles |
| JP2020176085A (en) * | 2019-04-17 | 2020-10-29 | ポーラ化成工業株式会社 | Wrinkle ameliorating composition |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025142558A1 (en) * | 2023-12-28 | 2025-07-03 | 株式会社 資生堂 | Cosmetic containing pyridoxine |
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2023120180A1 (en) | 2023-06-29 |
| CN118265517A (en) | 2024-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9839588B2 (en) | Skin external preparation comprising an aqueous dispersion of finely dispersed wax, nonionic surfactant, and ionic water-soluble thickener | |
| US20120022160A1 (en) | Composition for external use on skin | |
| JP5095799B2 (en) | Oil-in-water topical skin preparation | |
| JP2012017318A (en) | Liquid crystal and skin external preparation containing the same | |
| US11696886B2 (en) | Cosmetic | |
| JP2025060992A (en) | Adenosine phosphate-containing high-viscosity oil-in-water emulsion composition | |
| JP2025074109A (en) | O/W type low-viscosity emulsion composition containing adenosine phosphate | |
| JP7612387B2 (en) | Oil-in-water emulsion composition containing behendimonium ethyl stearyl phosphate | |
| WO2023068065A1 (en) | Water-in-oil emulsified cosmetic | |
| WO2023120180A1 (en) | Oil-in-water type emulsified cosmetic | |
| JP6368064B1 (en) | Novel composite and water-in-oil emulsion composition | |
| US10729629B2 (en) | Complex and emulsion composition | |
| WO2023095691A1 (en) | Oil-in-water emulsion cosmetic | |
| KR20200139252A (en) | New composite and emulsion composition | |
| WO2023047979A1 (en) | Oil-in-water emulsified cosmetic material | |
| WO2023120204A1 (en) | Oil-in-water emulsion cosmetic | |
| WO2019208497A1 (en) | Novel composite and emulsified composition | |
| WO2023074365A1 (en) | Oil-in-water emulsion cosmetic | |
| JP6469286B1 (en) | Novel composite and emulsion composition | |
| WO2023100683A1 (en) | Oil-in-water emulsion cosmetic | |
| US20140031437A1 (en) | Oil-in-water emulsions | |
| WO2025110033A1 (en) | Cosmetic | |
| JP2004123727A (en) | Skin care preparation for external use of oil-in-water emulsion type | |
| JP2023079572A (en) | Oil-in-water emulsified cosmetic | |
| WO2023106121A1 (en) | Oil-in-water emulsion cosmetic |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22910892 Country of ref document: EP Kind code of ref document: A1 |
|
| ENP | Entry into the national phase |
Ref document number: 2023569277 Country of ref document: JP Kind code of ref document: A |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 202280076891.1 Country of ref document: CN |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 22910892 Country of ref document: EP Kind code of ref document: A1 |